As per the research report, the size of the Latin America Wound Debridement Products market is valued at USD 74.29 million in 2022. It is expected to grow at a CAGR of 7.3% to reach USD 105.67 million by 2027 during the forecast period 2022 to 2027. It captures 12% of the global market.
Wound debridement is a process of removal of contaminated, dead tissue along with foreign substances from a wound. Wound debridement products help to decrease various types of toxins, microbes, and other foreign material that hinders the healing of the wound.
Growing incidence of hard and heal wounds, augmenting the geriatric population, increase in the prevalence of chronic diseases, rising adoption of debridement products and techniques and growth in patients population are fuelling the market. Additionally, higher demand for improved healthcare, better reimbursement policy, high healthcare expenditure, and cost-effectiveness are the secondary factors driving the market.
On the other hand, the economic downturn is inhibiting the growth of the market.
This research report on the Latin America Wound Debridement Products Market has been segmented and sub-segmented into the following categories:
By Method of Debridement:
By Type of Wound:
By Product:
By Country:
Prominent companies leading in the Latin America Wound Debridement Products Market profiled in the report are Coloplast A/S, ArthroCare Corporation, Advanced Medical Solutions Group plc, and Misonix, Inc. Other players in the market include MediWound Ltd, Derma Sciences, Inc., PuriCore plc and Smith & Nephew Plc.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]